drugset / Trial / NCT04771143
Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056
RandomizedParallel-groupDouble-blindOther
Summary
This is a study to assess safety, tolerability and interactions of AFQ056 and cocaine in patients with cocaine use disorder.
Timeline
- Start
- 2021-07-21
- Primary completion
- 2022-01-03
- Completion
- 2022-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mavoglurant | Small molecule | 200 mg | Oral |